Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer. - Wikidata - awgldk - TriplyDB

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

http://www.wikidata.org/entity/Q34444495

about

Genomic diversity of colorectal cancer: Changing landscape and emerging targets Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer Recent developments in receptor tyrosine kinases targeted anticancer therapy Missing metastases as a model to challenge current therapeutic algorithms in colorectal liver metastases Cytokine-Induced Modulation of Colorectal Cancer Adjuvant chemotherapy for rectal cancer: Is it needed?Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review A Comprehensive Review of Clinical Trials on EGFR Inhibitors Such as Cetuximab and Panitumumab as Monotherapy and in Combination for Treatment of Metastatic Colorectal Cancer Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer Treatment-related gastrointestinal toxicities and advanced colorectal or pancreatic cancer: A critical update Molecular profiling in the treatment of colorectal cancer: focus on regorafenib New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?Timing and extent of response in colorectal cancer: critical review of current data and implication for future trials Anti-angiogenic agents in metastatic colorectal cancer Association between Polymorphisms in Vascular Endothelial Growth Factor Gene and Response to Chemotherapies in Colorectal Cancer: A Meta-Analysis Review on the Applications and Molecular Mechanisms of Xihuang Pill in Tumor Treatment New Perspectives in the Treatment of Colorectal Metastases Combination therapeutics in complex diseases Oral drugs in the treatment of metastatic colorectal cancer.Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine.CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.Antibody Therapies in Cancer.Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy Multidisciplinary approach of colorectal cancer liver metastases.Prognostic value of circulating endothelial cells in metastatic colorectal cancer.Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancer.Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis.Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients.Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer--results from a non-interventional observation study.DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan.High-throughput RNAi screening of human kinases identifies predictors of clinical outcome in colorectal cancer patients treated with oxaliplatin.Survival Benefit and Safety of Bevacizumab in Combination with Erlotinib as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: A Meta-Analysis.Endothelial Rac1 is essential for hematogenous metastasis to the lung Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials.Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer.

P2860

Q26739052-80C31A61-E228-457B-B20D-9E171AC1F193 Q26748924-9290861A-1644-4511-9688-327FF2140BEB Q26751331-F195BAD8-D561-4355-9DA7-274294272F91 Q26751389-85825E1C-AF56-4FDA-9636-A1C91016D508 Q26752374-571CB816-A827-42EC-BC54-6F11A259AFB7 Q26775099-C8E4CD37-729C-4BC1-A66C-10C07AE737B8 Q26775522-2EDB0CBF-0704-4CFB-AA0D-D86856796E21 Q26775711-C950DD84-8D2F-4814-B6D7-506504972BC9 Q26775949-F9529B54-5941-4979-83F0-A2781270F37F Q26778004-F2DA945B-7519-4F31-8E7D-F7C145E50A95 Q26778296-FF736A46-8235-4598-B9AA-30E9C37F9BCB Q26796348-33636E1C-2E09-4860-B4F8-70F1254BBDE1 Q26797292-B72E5E49-6673-495D-97EB-78489F1D7486 Q26801911-0F503B37-F9A7-474D-AA9F-370A0527D909 Q26862559-49A61E0C-C0BB-4554-B684-F75DC2C0D62A Q27009539-CBE5F4DC-14A4-43EA-A7EE-B0F4E624E214 Q28073788-71F74D1C-9518-414C-9B54-A257C73FD02D Q28076891-ADD3E743-1994-4189-9782-CDC3F0AA80B2 Q30251387-0AF8FCEE-04CE-41B6-9F14-74B3710323EB Q30279055-B2102CC7-03CE-4938-BB21-6A906AD1C1F1 Q30353497-824807D1-6440-4B53-B8F0-98C7C5EE890A Q30855372-A9989791-4754-4E80-AB8E-C93A17071536 Q31104000-8219C433-DE4D-4751-B59C-AAA14C28CB2F Q33624491-F2FA09AB-96AE-49A4-8C0D-CFE417036026 Q33725671-2304B82D-D5CE-490B-88A8-9873C7571BBB Q33739235-D5311172-B7C9-441B-A09A-958581C75BD4 Q33779859-E5E9D11B-E71F-471B-B716-A4E0C449B4E1 Q33913995-C1D801EE-27C6-4E7B-B88E-BD3874BB597C Q34492273-EAC820C9-CB18-4F8F-A1A1-878C64C4EE7E Q35585759-B6313C6E-9C79-469D-BF45-397264141F8A Q35600456-851B9341-BB3E-4E9D-8586-A7356A505D4A Q35685684-6DA004A9-C8B0-431E-87C1-AD04D06D1BCA Q35814479-587BF263-F66A-4B50-ABFB-A37FF86A431E Q35920292-84379E1B-9B1C-4973-8413-525063F6E0F7 Q36072520-208F4AAC-FA03-4E4D-8A90-8224EA55F8DD Q36140973-4E00840E-363E-48EA-A1EA-D25D75C278F9 Q36143977-3D7359CC-ABD2-4967-90B2-31E0C3EBC064 Q36232086-083CFBBA-2CE9-4A4C-B926-3F4CB75E78DA Q36316649-E5C91BC1-7D4A-4729-BBF2-4DA35CB30D2C Q36324953-3311383C-A3AA-4C4E-80E8-C1E5149DE53C

P2860

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

http://www.wikidata.org/entity/Q34444495

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

@ast

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

@en

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

@nl

type

label

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

@ast

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

@en

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

@nl

prefLabel

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

@ast

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

@en

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

@nl

P1433

Q34444495-7B00547B-29D5-4EC0-8D93-471F1C00B92B

P1476

Q34444495-2F7E0419-7B28-4701-8A90-881C2E107F97

P2093

Q34444495-0F24A4EA-6E7E-4CFC-B289-44C0D2BCCDD1

Q34444495-3DCCCB20-52DE-48F3-90E4-B850D4921DFE

Q34444495-78A3C1C1-E511-490F-8DA5-1554C93E965E

Q34444495-8A9D78DA-5FC0-41D9-A0E2-440AA3CF2CB2

Q34444495-A31C9E06-EE6E-48F9-B4AE-CDFE1819D418

Q34444495-DCD2FA0F-6C0E-49B6-8809-85739535AEEA

Q34444495-DE296EBF-6A3A-4E9F-876A-0AD8EC58C342

Q34444495-E4F79740-D95F-4440-B6FE-DC66AF0C4929

Q34444495-F2FBD7AA-09B7-4E6D-8703-1C0EEAA98C44

Q34444495-F5F27B3A-1CB8-40AB-9011-A332C08F2E5F

P304

Q34444495-D3E23AC0-8CA4-4210-8AE6-D8C4E4A1E981

P31

Q34444495-0BA1D260-746E-44D7-BB54-7B06B906F7BF

P356

Q34444495-E11222D2-25DA-4C4E-AAD4-D3ECBABDA335

P407

Q34444495-23082869-0428-4A5A-A21A-3EC26981D049

P433

Q34444495-47E8D522-931D-4AB0-86CF-FA6D8BE0EFDB

P478

Q34444495-F7A8D733-20AB-4B13-97EF-0B2345365658

P50

Q34444495-355FAC4F-A4B6-4644-8319-654B8522EFC4

Q34444495-3E3A04D1-2517-4451-A322-556CC35101E9

Q34444495-3E502810-56F9-41D3-9C27-C71BAEC14736

Q34444495-45F7E101-D941-4875-94D6-C5DE3FD95657

Q34444495-A2579177-5CAB-4C83-B95D-F5A2E92B8AB7

Q34444495-E0044B3B-A5C1-4540-A33C-0805EBEA381B

Q34444495-E758ACEB-D0A3-4DAE-A739-D0FD5CEC54C0

Q34444495-EEB9CB48-DAC4-4DE9-BFCA-AC725D093C94

Q34444495-EEC7B633-447C-4132-84B1-AAB3E249B0E9

P577

Q34444495-C930F39D-2414-4965-AFB3-5252CA3977BF

P698

Q34444495-E754BFFE-AE26-47F7-9EE9-80F1A39BF0CC

P921

Q34444495-A2722C20-0575-4D48-A16B-7F73F82345B4

Q34444495-C3995572-29FE-4BAD-B8AF-EF1C6D3EACED

P356

P1433

The New England Journal of Medicine

P1476

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer

@en

P2093

Alberto Zaniboni

http://www.w3.org/2001/XMLSchema#string

Chiara Carlomagno

http://www.w3.org/2001/XMLSchema#string

Corrado Boni

http://www.w3.org/2001/XMLSchema#string

Domenico Amoroso

http://www.w3.org/2001/XMLSchema#string

Enrico Cortesi

http://www.w3.org/2001/XMLSchema#string

Giacomo Allegrini

http://www.w3.org/2001/XMLSchema#string

Gianluca Masi

http://www.w3.org/2001/XMLSchema#string

Gianluca Tomasello

http://www.w3.org/2001/XMLSchema#string

Luca Boni

http://www.w3.org/2001/XMLSchema#string

Rosella Spadi

http://www.w3.org/2001/XMLSchema#string

P304

1609-1618

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1403108

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

371

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Tonini

Angela Buonadonna

Fotios Loupakis

Alfredo Falcone

Chiara Cremolini

Vittorina Zagonel

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25337750

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer